Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli36603

Last updated on 22-8-2019 by Anonymous (non vérifié)

Public Access


Peer reviewed scientific article



33 patients with serious gram-negative bacillary infections were treated with cefotaxime. In patients with normal renal function the dose varied between 1.5 to 4 g/day. 17 patients had urinary tract infections, 5 respiratory tract infections, 1 combined urinary tract infection and respiratory tract infection, and 10 miscellaneous infections. 16 patients had septicemia. 25 infections were due to pathogens resistant in vitro to ampicillin, cephalothin, gentamicin and/or tobramycin. 15 infections had failed to respond to ampicillin, cefazolin, gentamicin or tobramycin therapy. 3⅔3 patients r…

Associated health topics:

QR code

QR code for this page URL